Plasmid-DNA Delivery by Covalently Functionalized PEI-SPIONs as a Potential 'Magnetofection' Agent.

cytotoxicity ligand exchange magnetofection pentafluorophenyl ester plasmid-DNA superparamagnetic iron oxide nanoparticles (SPIONs) surface functionalization transfection

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
01 Nov 2022
Historique:
received: 07 10 2022
revised: 25 10 2022
accepted: 27 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Nanoformulations for delivering nucleotides into cells as vaccinations as well as treatment of various diseases have recently gained great attention. Applying such formulations for a local treatment strategy, e.g., for cancer therapy, is still a challenge, for which improved delivery concepts are needed. Hence, this work focuses on the synthesis of superparamagnetic iron oxide nanoparticles (SPIONs) for a prospective "magnetofection" application. By functionalizing SPIONs with an active catechol ester (CafPFP), polyethyleneimine (PEI) was covalently bound to their surface while preserving the desired nanosized particle properties with a hydrodynamic size of 86 nm. When complexed with plasmid-DNA (pDNA) up to a weight ratio of 2.5% pDNA/Fe, no significant changes in particle properties were observed, while 95% of the added pDNA was strongly bound to the SPION surface. The transfection in A375-M cells for 48 h with low amounts (10 ng) of pDNA, which carried a green fluorescent protein (GFP) sequence, resulted in a transfection efficiency of 3.5%. This value was found to be almost 3× higher compared to Lipofectamine (1.2%) for such low pDNA amounts. The pDNA-SPION system did not show cytotoxic effects on cells for the tested particle concentrations and incubation times. Through the possibility of additional covalent functionalization of the SPION surface as well as the PEI layer, Caf-PEI-SPIONs might be a promising candidate as a magnetofection agent in future.

Identifiants

pubmed: 36364241
pii: molecules27217416
doi: 10.3390/molecules27217416
pmc: PMC9655526
pii:
doi:

Substances chimiques

Polyethyleneimine 9002-98-6
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : AL 552/17-1

Références

Hum Exp Toxicol. 2016 Apr;35(4):377-87
pubmed: 26134983
Int J Nanomedicine. 2012;7:5577-91
pubmed: 23144561
Int J Nanomedicine. 2019 Oct 24;14:8421-8432
pubmed: 31749616
J Pharm Sci. 1998 Feb;87(2):130-46
pubmed: 9519144
Int J Nanomedicine. 2018 Mar 28;13:1899-1915
pubmed: 29636608
J Pharm Sci. 2000 Jan;89(1):76-87
pubmed: 10664540
Adv Healthc Mater. 2020 Jan;9(1):e1901223
pubmed: 31794153
Mater Sci Eng C Mater Biol Appl. 2019 May;98:1252-1276
pubmed: 30813007
Small. 2013 May 27;9(9-10):1521-32
pubmed: 23019091
Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2802-2810
pubmed: 28778487
Adv Drug Deliv Rev. 2013 Jan;65(1):71-9
pubmed: 23088862
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2325-2330
pubmed: 28193901
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11613-8
pubmed: 18697944
Eur J Pharm Biopharm. 2016 Apr;101:152-62
pubmed: 26854862
Int J Pharm. 2012 Feb 14;423(1):16-25
pubmed: 21703340
ACS Nano. 2017 Mar 28;11(3):2313-2381
pubmed: 28290206
Nanomedicine. 2013 Oct;9(7):961-71
pubmed: 23669367
J Colloid Interface Sci. 2015 Jan 15;438:244-248
pubmed: 25454448
ACS Appl Mater Interfaces. 2016 Jan 27;8(3):2393-8
pubmed: 26730845
Nucleic Acids Res. 2006 Mar 15;34(5):e40
pubmed: 16540591
Environ Toxicol Chem. 2014 Mar;33(3):481-92
pubmed: 24273100
J Mater Sci Mater Med. 2012 Nov;23(11):2697-708
pubmed: 22826003
Nat Chem Biol. 2015 Sep;11(9):691-6
pubmed: 26214255

Auteurs

René Stein (R)

Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kroener-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Felix Pfister (F)

Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kroener-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Bernhard Friedrich (B)

Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kroener-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Pascal-Raphael Blersch (PR)

Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kroener-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Harald Unterweger (H)

Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kroener-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Anton Arkhypov (A)

Department of Chemistry and Pharmacy, Organic Chemistry II, Friedrich-Alexander-University Erlangen-Nürnberg, 91058 Erlangen, Germany.

Andriy Mokhir (A)

Department of Chemistry and Pharmacy, Organic Chemistry II, Friedrich-Alexander-University Erlangen-Nürnberg, 91058 Erlangen, Germany.

Mikhail Kolot (M)

Department of Biochemistry and Molecular Biology, School of Neurobiology, Biochemistry &Biophysics, Tel-Aviv University, Tel-Aviv 6997801, Israel.

Christoph Alexiou (C)

Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kroener-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Rainer Tietze (R)

Department of Otorhinolaryngology-Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kroener-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Articles similaires

Humans Robotic Surgical Procedures Male Female Aged
Humans Hernias, Diaphragmatic, Congenital Case-Control Studies Prospective Studies Sweden

UK Foot and Ankle Thromboembolism (UK-FATE).

Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra et al.
1.00
Humans Venous Thromboembolism Male Female United Kingdom
Nephrectomy Humans Robotic Surgical Procedures Pneumoperitoneum, Artificial Insufflation

Classifications MeSH